BEONE MEDICINES LTD. (ONC) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
BEONE MEDICINES LTD. (ONC) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$2.12 BLiabilities$4.00 BCurrent assets$7.22 BAssets$9.18 BNon-current liabilities$1.88 BEquity$5.17 BGross equity(calculated)$13.05 BNon-current assets$1.96 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, netInventories, netPrepaid expenses and other current assetsProperty, plant and equipment, netOperating lease right-of-use assetsOther non-current assetsIntangible assets, netAccrued expenses and other payablesAccounts payableShort-term debtSale of future royalty liability, current portionTax payableOperating lease liabilities, current portionResearch and development cost share liability, current portionLong-term debtSale of future royalty liability, non-current portionOther long-term liabilitiesDeferred tax liabilitiesOperating lease liabilities, non-current portionAdditional paid-in capitalOrdinary shares, $0.0001 par value per share; 1,540,975,898 and 1,540,975,898 shares issued and 1,469,278,815 and 1,441,075,618 shares outstanding as of June 30, 2026 and December 31, 2025, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccumulated other comprehensive lossAccrued expenses and other payablesAccrued expenses and other payables$1.26 BAccounts payableAccounts payable$470.30 MCurrent liabilitiesCurrent liabilities$2.12 BShort-term debtShort-term debt$190.90 MSale of future royalty liability, current portionSale of future royalty liability, current portion$89.28 MLiabilitiesLiabilities$4.00 BTax payableTax payable$76.32 MOperating lease liabilities, current portionOperating lease liabilities, current portion$21.95 MCurrent assetsCurrent assets$7.22 BResearch and development cost share liability, current portionResearch and development costshare liability, current portion$6.18 MAssetsAssets$9.18 BLong-term debtLong-term debt$882.16 MCash and cash equivalentsCash and cash equivalents$5.10 BNon-current liabilitiesNon-current liabilities$1.88 BSale of future royalty liability, non-current portionSale of future royalty liability, non-current portion$817.04 MOther long-term liabilitiesOther long-term liabilities$77.64 MAccounts receivable, netAccounts receivable, net$1.06 BEquityEquity$5.17 BDeferred tax liabilitiesDeferred tax liabilities$57.39 MInventories, netInventories, net$732.60 MOperating lease liabilities, non-current portionOperating lease liabilities, non-current portion$48.20 MGross equity (calculated)Gross equity(calculated)$13.05 BPrepaid expenses and other current assetsPrepaid expenses and other current assets$328.98 MProperty, plant and equipment, netProperty, plant and equipment, net$1.64 BNon-current assetsNon-current assets$1.96 BOperating lease right-of-use assetsOperating lease right-of-use assets$145.99 MOther non-current assetsOther non-current assets$109.58 MIntangible assets, netIntangible assets, net$60.96 MAdditional paid-in capitalAdditional paid-in capital$13.05 BOrdinary shares, $0.0001 par value per share; 1,540,975,898 and 1,540,975,898 shares issued and 1,469,278,815 and 1,441,075,618 shares outstanding as of June 30, 2026 and December 31, 2025, respectivelyOrdinary shares$147.00 KAccumulated deficitAccumulated deficit−$7.86 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$25.37 M
Chart details

BEONE MEDICINES LTD. (ONC) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
9,175,615,000 US dollars
Current assets
7,215,805,000 US dollars
Non-current assets
1,959,810,000 US dollars
Liabilities
4,001,617,000 US dollars
Current liabilities
2,119,187,000 US dollars
Non-current liabilities
1,882,430,000 US dollars
Equity
5,173,998,000 US dollars
Cash and cash equivalents
5,098,041,000 US dollars
Accounts receivable, net
1,056,177,000 US dollars
Inventories, net
732,603,000 US dollars
Prepaid expenses and other current assets
328,984,000 US dollars
Property, plant and equipment, net
1,643,286,000 US dollars
Operating lease right-of-use assets
145,987,000 US dollars
Other non-current assets
109,581,000 US dollars
Intangible assets, net
60,956,000 US dollars
Accrued expenses and other payables
1,264,264,000 US dollars
Accounts payable
470,299,000 US dollars
Short-term debt
190,896,000 US dollars
Sale of future royalty liability, current portion
89,278,000 US dollars
Tax payable
76,315,000 US dollars
Operating lease liabilities, current portion
21,953,000 US dollars
Research and development cost share liability, current portion
6,182,000 US dollars
Long-term debt
882,163,000 US dollars
Sale of future royalty liability, non-current portion
817,035,000 US dollars
Other long-term liabilities
77,644,000 US dollars
Deferred tax liabilities
57,388,000 US dollars
Operating lease liabilities, non-current portion
48,200,000 US dollars
Additional paid-in capital
13,054,760,000 US dollars
Ordinary shares, $0.0001 par value per share; 1,540,975,898 and 1,540,975,898 shares issued and 1,469,278,815 and 1,441,075,618 shares outstanding as of June 30, 2026 and December 31, 2025, respectively
147,000 US dollars
Accumulated deficit
negative 7,855,539,000 US dollars
Accumulated other comprehensive loss
negative 25,370,000 US dollars
Gross equity (calculated)
13,054,907,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
BEONE MEDICINES LTD. (ONC) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!